Market Overview

Rosacea | A Drug Pipeline Analysis Report 2018| Technavio

Share:

Technavio has announced their latest drug pipeline analysis report on rosacea.
The report includes a detailed analysis of the pipeline molecules under
investigation within the defined data collection period to treat rosacea.

This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20180727005546/en/

Technavio has published a new report on the drug development pipeline for rosacea, including a detai ...

Technavio has published a new report on the drug development pipeline for rosacea, including a detailed study of the pipeline molecules. (Graphic: Business Wire)

This report by Technavio
presents a detailed analysis of the market, including regulatory
framework, drug development strategies, recruitment strategies, and key
companies that are expected to play an essential role in the growth of
the market in the future.

This report is available at a USD 1,000 discount for a limited time
only:
View
market snapshot before purchasing

Rosacea: Market overview

Rosacea is a commonly occurring skin condition that is mistaken for
acne, an allergic reaction, or any other skin problems. This skin
condition can be aggravated by factors such as alcohol, extreme
temperature, sunlight, wind, emotions, hot drinks, spicy food,
cosmetics, and drugs prescribed to dilate blood vessels. This disorder
has numerous symptoms such as facial redness, swollen red bumps, eye
problems, and enlarged nose.

According to a senior market research analyst at Technavio, "The
National Institutes of Arthritis and Musculoskeletal and Skin Diseases
stated in their research that rosacea can occur to any individual;
however, it is prevalent in adults aged 30 to 60 years, women during
menopause condition, and people with fair skin."

Rosacea: Segmentation analysis

This pipeline analysis report segments the rosacea market based on
therapies employed (monotherapy), RoA (topical and oral), therapeutic
modality (small molecule, biological, and peptides), targets (30S
ribosomal subunit, 14-alpha-demethylase, ammonia, keratinocyte,
proteasome, serine protease, toll-like receptor (TLR), and TRPV1
receptor), MoA (Protein 30S ribosomal subunit inhibitors,
14-alpha-demethylase inhibitors, cell membrane permeability enhancers,
keratinocyte inhibitors, nitric oxide donor, proteasome inhibitors,
serine protease inhibitors, TLR modulator, and TRPV1 receptor
antagonists), geographical segmentation (US, Germany, UK, the
Netherlands, Australia, Canada, France, New Zealand, Sweden, and South
Korea) and recruitment status (active, not recruiting, completed, not
yet recruiting, and recruiting). It provides an in-depth analysis of the
prominent factors influencing the market, including drivers,
opportunities, trends, and industry-specific challenges.

Based on therapeutic modality, more than 73% of the molecules that are
being investigated for the treatment of rosacea are small molecules.

Looking for more information on this market? Request
a free sample report

Technavio's sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Scope of the Report

Regulatory Framework

Drug Development Landscape

  • Drugs under development
  • Indications coverage

Drug Development Strategies

  • Therapies employed
  • RoA
  • Therapeutic modality
  • Geographical coverage

Recruitment Strategies

  • Recruitment status
  • Gender
  • Age

Key Companies

  • Type of players
  • Company overview

Discontinued or Dormant Molecules

About Technavio

Technavio
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio's comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team
at media@technavio.com.

View Comments and Join the Discussion!